Anivive Announces Completion of LAVERDIA®-CA1 Pivotal Field Study for Canine Lymphoma
Anivive, a software-driven pet health company, today announced the successful completion of its pivotal field study evaluating the safety and effectiveness of LAVERDIA®-CA1 (verdinexor tablets) in ...
Innocan Pharma Corporation: Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis
This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...
Velico Medical, Inc: South Texas Blood and Tissue Center First US Civilian Blood Center to Install Velico's FrontlineODP System
Velico, Inc. has launched a groundbreaking collaboration with the South Texas Blood and Tissue Center (STBT), a subsidiary of San Antonio-based ...
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Here’s What the FDA Label on Your Personal Care Products Means
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
Outlook Therapeutics announces upcoming anticipated milestones
Resubmission of the ONS-5010 BLA targeted for Q1 CY2025; Initial commercial launches in Germany and the UK planned to commence in Q2 CY2025; ...
News Medical on MSN20h
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Food Safety News5d
FDA warns two companies over foreign supplier verification violations
Business owners have 15 days to respond to FDA warning letters. Warning letters often are not issued until a company has been given months to years to correct problems. The FDA has issued warning ...
Implantica announces positive feedback received from U.S. FDA of the RefluxStop™ PMA Module 2 submission
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field ...
F1 Team's Title Sponsor In Hot Water After Controversial Ad Leaves It Banned In UK
The impact on Stake is immediate and has operational repercussions managed by TGP Europe Limited, which oversees the site as ...
Food Safety News12d
FDA warns seafood companies over HACCP violations and potentially adulterated products
Business owners have 15 days to respond to FDA warning letters. Warning letters often are not issued until a company has been given months to years to correct problems. The FDA has issued warning ...